COLLEEN BARRY: Open Payments
NPI 1023498623 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,703 in 172 payments from 23 companies in 2025. Trend: 2023 $5,928 · 2024 $8,274 · 2025 $14,703
Speaker / faculty: $10,120Food & beverage: $3,643Consulting: $560Travel & lodging: $380
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 28 | $11,546 |
| ABBVIE INC. | 26 | $530 |
| Teva Pharmaceuticals USA, Inc. | 12 | $345 |
| Neurocrine BioSciences, Inc. | 12 | $267 |
| Indivior Inc. | 20 | $215 |
| Axsome Therapeutics, Inc. | 3 | $182 |
| Aimmune Therapeutics, Inc. | 2 | $171 |
| Lundbeck LLC | 12 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $151 |
| Otsuka America Pharmaceutical, Inc. | 11 | $137 |
Products named: VIVITROL, VRAYLAR, AUSTEDO XR, REXULTI, INGREZZA, SUBLOCADE, Auvelity, ZENPEP.
Industry payments across OH — which companies pay providers there.
